PERCEPTIVE ADVISORS LLC Q4 2019 Filing
Filed February 14, 2020
Portfolio Value
$6.2B
Holdings
114
Report Date
Q4 2019
Filing Type
13F-HR
All Holdings (114 positions)
| Stock | Value |
|---|---|
SWTXSPRINGWORKS THERAPEUTICS INC | $1.3T |
GBTUSDGLOBAL BLOOD THERAPEUTICS INC | $466.3B |
MRTXEURMIRATI THERAPEUTICS INC | $412.8B |
NBIXNEUROCRINE BIOSCIENCES INC | $388.3B |
KODKODIAK SCIENCES INC | $263.6B |
IOVAIOVANCE BIOTHERAPEUTICS INC | $260.6B |
AM6AMICUS THERAPEUTICS INC | $244.8B |
—ZOGENIX INC | $193.4B |
ATNXEURATHENEX INC | $176.1B |
AMRNAMARIN CORPORATION PLC | $152.4B |
BBIOBRIDGEBIO PHARMA INC | $142.3B |
MGTXMEIRAGTX HOLDINGS PLC | $128.8B |
—QUOTIENT LTD | $126.4B |
—ZYMEWORKS INC | $109.2B |
NVROEURNEVRO CORP | $89.8B |
—MYOKARDIA INC | $87.9B |
—KADMON HOLDINGS INC | $66.3B |
CRNXCRINETICS PHARMACEUTICALS INC | $64.9B |
VAC2USDVBI VACCINES INC | $63.4B |
—MOMENTA PHARMACEUTICALS INC | $55.9B |
VRCAVERRICA PHARMACEUTICALS INC | $52.0B |
RCKTROCKET PHARMACUETICALS INC | $51.0B |
—FREQUENCY THERAPEUTICS INC | $49.8B |
2L9BLUEPRINT MEDICINES CORP | $49.6B |
—DBV TECHNOLOGIES SA | $46.7B |
ADMAADMA BIOLOGICS INC | $46.1B |
PRVBUSDPROVENTION BIO INC | $43.5B |
BDQMALBIREO PHARMA INC | $43.3B |
ARNAEURARENA PHARMACEUTICALS INC | $43.3B |
AGIOAGIOS PHARMACEUTICALS INC | $43.0B |
—RETROPHIN INC | $41.0B |
ALLOALLOGENE THERAPEUTICS INC | $40.1B |
—EIDOS THERAPEUTICS INC | $40.0B |
—UROVANT SCIENCES LTD | $37.3B |
—FOAMIX PHARMACEUTICALS LTD | $37.3B |
—NEPTUNE WELLNESS SOLUTIONS INC | $36.8B |
—MOLECULAR TEMPLATES INC | $34.6B |
—SOLID BIOSCIENCES INC | $30.0B |
—AGILE THERAPEUTICS INC | $29.8B |
ESTAESTABLISHMENT LABS HOLDINGS INC | $29.1B |
ITCIEURINTRA-CELLULAR THERAPIES INC | $28.6B |
—TURNING POINT THERAPEUTICS I | $27.2B |
CTMXCYTOMX THERAPEUTICS INC | $27.0B |
BUWABIO-RAD LABORATORIES INC | $25.3B |
RGNXREGENXBIO INC | $24.9B |
—VAPOTHERM INC | $21.2B |
CNCEEURCONCERT PHARMACEUTICALS INC | $19.8B |
STOKSTOKE THERAPEUTICS INC | $19.0B |
EHTHEHEALTH INC | $19.0B |
TNDMTANDEM DIABETES CARE INC | $18.5B |
ALDXALDEYRA THERAPEUTICS INC | $17.9B |
YMABUSDY-MABS THERAPEUTICS INC | $17.6B |
TXG10X GENOMICS INC | $16.8B |
ARVNARVINAS INC | $16.4B |
ANABANAPTYSBIO INC | $16.3B |
AUPHAURINIA PHARMACEUTICALS INC | $14.5B |
RVNCEURREVANCE THERAPEUTICS INC | $13.3B |
—AQUESTIVE THERAPEUTICS INC | $13.1B |
ICPTUSDINTERCEPT PHARMACEUTICALS INC | $12.1B |
MORFMORPHIC HOLDING INC | $11.2B |
—MEI PHARMA INC | $10.9B |
—SC HEALTH CORP | $10.4B |
VRAYQVIEWRAY INC | $10.3B |
FULCFULCRUM THERAPEUTICS INC | $10.0B |
—IMMUNOVANT INC | $9.9B |
HCATHEALTH CATALYST INC | $9.8B |
—MOTUS GI HLDGS INC | $9.6B |
ADPTADAPTIVE BIOTECHNOLOGIES COR | $9.1B |
ALECALECTOR INC | $8.8B |
COLLCOLLEGIUM PHARMACEUTICAL INC | $8.7B |
IDYAIDEAYA BIOSCIENCES INC | $8.6B |
OPHTEURIVERIC BIO INC | $8.5B |
CERNCHFCERNER CORP | $7.7B |
ZBHZIMMER BIOMET HLDGS INC | $7.5B |
—NEOLEUKIN THERAPEUTICS INC | $6.2B |
VCRAUSDVOCERA COMMUNICATIONS INC | $6.2B |
VERUEURVERU INC | $5.5B |
NVTA1EURINVITAE CORP | $5.4B |
—ABEONA THERAPEUTICS INC | $4.9B |
TWSTTWIST BIOSCIENCE CORP | $4.5B |
—ACASTI PHARMA INC | $4.4B |
GRTXGALERA THERAPEUTICS INC | $4.3B |
ATECALPHATEC HOLDINGS INC | $4.0B |
RYTMRHYTHM PHARMACEUTICALS INC | $3.9B |
—TRANSLATE BIO INC | $3.5B |
—THERAPEUTICSMD INC | $2.7B |
CLDNEUREIGER BIOPHARMACEUTICALS INC | $2.1B |
ARWRARROWHEAD PHARMACEUTICALS INC | $1.9B |
PHRPHREESIA INC | $1.9B |
XBISPDR SERIES TRUST | $1.6B |
AXNX*AXONICS MODULATION TECH INC | $1.5B |
AORTCRYOLIFE INC | $1.4B |
SWAVUSDSHOCKWAVE MED INC | $1.3B |
KPTIEURKARYOPHARM THERAPEUTICS INC | $1.0B |
RACEFERRARI N.V. | $1.0B |
—SELECT INTERIOR CONCEPTS INC | $945.0M |
—SIERRA ONCOLOGY INC | $910.0M |
DCPHEURDECIPHERA PHARMACEUTICALS INC | $892.0M |
—DICERNA PHARMACEUTICALS INC | $804.0M |
NVCRNOVOCURE LTD | $800.0M |
Page 1 of 2Next